These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30454007)

  • 21. Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).
    Wu W; Zhang Z; Gao XH; Shen Z; Jing Y; Lu H; Li H; Yang X; Cui X; Li Y; Lou Z; Liu P; Zhang C; Zhang W
    Oncotarget; 2017 Mar; 8(13):21639-21649. PubMed ID: 28423493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma protein-based signature predicts distant metastasis and induction chemotherapy benefit in Nasopharyngeal Carcinoma.
    Liang Y; Li J; Li Q; Tang L; Chen L; Mao Y; He Q; Yang X; Lei Y; Hong X; Zhao Y; He S; Guo Y; Wang Y; Zhang P; Liu N; Li Y; Ma J
    Theranostics; 2020; 10(21):9767-9778. PubMed ID: 32863958
    [No Abstract]   [Full Text] [Related]  

  • 23. Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy.
    Chen W; Li Y; Yuan D; Peng Y; Qin J
    Thorac Cancer; 2018 Aug; 9(8):956-966. PubMed ID: 29893036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study).
    Yang Y; Zhou T; Chen X; Li J; Pan J; He X; Lin L; Shi YR; Feng W; Xiong J; Yang K; Yu Q; Zhang Q; Hu D; Sun Y; Hu G; Li P; Shen L; Lin Q; Zhang B; Qu X; Zou J; Zhang L; Fang W; Zhao Y
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34933967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Tumor Cells Correlate with Clinicopathological Features and Outcomes in Differentiated Thyroid Cancer.
    Qiu ZL; Wei WJ; Sun ZK; Shen CT; Song HJ; Zhang XY; Zhang GQ; Chen XY; Luo QY
    Cell Physiol Biochem; 2018; 48(2):718-730. PubMed ID: 30025398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies.
    Ye Z; Ding Y; Chen Z; Li Z; Ma S; Xu Z; Cheng L; Wang X; Zhang X; Ding N; Zhang Q; Qian Q
    Cancer Biol Ther; 2019; 20(4):546-551. PubMed ID: 30572767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolutionary Expression of HER2 Conferred by Chromosome Aneuploidy on Circulating Gastric Cancer Cells Contributes to Developing Targeted and Chemotherapeutic Resistance.
    Li Y; Zhang X; Liu D; Gong J; Wang DD; Li S; Peng Z; Li Y; Wang X; Lin PP; Li M; Shen L
    Clin Cancer Res; 2018 Nov; 24(21):5261-5271. PubMed ID: 30012565
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy.
    Vo JH; Nei WL; Hu M; Phyo WM; Wang F; Fong KW; Tan T; Soong YL; Cheah SL; Sommat K; Low H; Ling B; Ng J; Tan WL; Chan KS; Oon L; Ying JY; Tan MH
    Sci Rep; 2016 Dec; 6(1):13. PubMed ID: 28442757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of circulating tumor cells and its association with the expression of cancer stem cells in nasopharyngeal carcinoma patients.
    Lu L; Huang HW; Du H; Liu ZX; Zha ZQ; Wang PP; Wu Y; Liu X; Weng CY; Fang XS; Li BX; Mao HB; Wang LN; Wang XP; Guan MM; Liu GL
    Neoplasma; 2022 Mar; 69(2):303-310. PubMed ID: 35068161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomas.
    Li M; Gao F; Ren X; Dong G; Chen H; Lin AY; Wang DD; Liu M; Lin PP; Shen S; Jiang H; Yang C; Zhang X; Zhao X; Zhu Q; Li M; Cui Y; Lin S
    Cancer Sci; 2022 Oct; 113(10):3535-3546. PubMed ID: 35940591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of circulating tumor cells combined with negative enrichment and CD45-FISH identification in diagnosis, therapy monitoring and prognosis of primary lung cancer.
    Chen YY; Xu GB
    Med Oncol; 2014 Dec; 31(12):240. PubMed ID: 25361883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of Circulating Tumor Cells in Bladder Cancer by Subtraction Enrichment and Immunostaining-fluorescence
    Yang YB; Bai YJ; Tang Y; Liu ZH; Wei Q; Han P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 48(4):605-609. PubMed ID: 28752983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.
    Chen Z; Long L; Wang K; Cui F; Zhu L; Tao Y; Wu Q; Xiang M; Liang Y; Qiu S; Xiao Z; Yi B
    Oncotarget; 2016 Jun; 7(23):34022-37. PubMed ID: 27145374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization.
    Zhang Y; Li J; Wang L; Meng P; Zhao J; Han P; Xia J; Xu J; Wang L; Shen F; Zheng A; Zhou F; Fan R
    Mol Med Rep; 2019 Aug; 20(2):1551-1560. PubMed ID: 31257510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biphasic co-detection of melanoma aneuploid tumor cells and tumor endothelial cells in guidance of specifying the field cancerized surgical excision margin and administering immunotherapy.
    Fu Z; Zhang L; Chen R; Zhan J; Zhong J; Zheng W; Zou J; Wang P; Deng X; Lin AY; Wang DD; Lin PP; He R
    Cancer Lett; 2024 Aug; 598():217099. PubMed ID: 38971491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vimentin expression in circulating tumor cells (CTCs) associated with liver metastases predicts poor progression-free survival in patients with advanced lung cancer.
    Wang Y; Liu Y; Zhang L; Tong L; Gao Y; Hu F; Lin PP; Li B; Zhang T
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):2911-2920. PubMed ID: 31646374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating Tumor Cells and Fibronectin 1 in the Prognosis of Nasopharyngeal Carcinoma.
    Yu Y; Lin ZX; Li HW; Luo HQ; Yang DH; Zhou HC; Jiang DX; Zhan DC; Yang L; Liang XY; Yu ZH; Chen ZH
    Technol Cancer Res Treat; 2020; 19():1533033820909911. PubMed ID: 32281480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of circulating tumor cells in patients with locally advanced head and neck squamous cell carcinoma.
    Liu K; Chen N; Wei J; Ma L; Yang S; Zhang X
    Oncol Rep; 2020 May; 43(5):1525-1535. PubMed ID: 32323844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model.
    Jiang J; Wang DD; Yang M; Chen D; Pang L; Guo S; Cai J; Wery JP; Li L; Li HQ; Lin PP
    Oncotarget; 2015 Jun; 6(17):15639-51. PubMed ID: 25909226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China.
    Ji MF; Huang QH; Yu X; Liu Z; Li X; Zhang LF; Wang P; Xie SH; Rao HL; Fang F; Guo X; Liu Q; Hong MH; Ye W; Zeng YX; Cao SM
    Cancer; 2014 May; 120(9):1353-60. PubMed ID: 24477877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.